Wegmans CEO named in top ‘Fit 50’ by Fitness magazine
ROCHESTER, N.Y. Fitness magazine named Danny Wegman, chief executive officer of Wegmans Food Markets, to its first-ever Fit 50 List, which appears in the magazine’s November/December 2008 issue on newsstands October 10, the grocer announced Friday.
The list, according to executive editor Pam O’Brien, “celebrates the top doctors, lawmakers, athletes, business owners, activists and visionaries who effected real change in women’s health and fitness in 2008.”
Wegman has been designated the “Healthy Grocery Guru,” and among the reasons cited for his selection is the company’s effort to keep prices low at a time of rising food prices. “It’s tough out there right now,” Wegman said. “If we make a little less money in the short term, that’s okay.”
Zebra to provide industry printer services to Managed Healthcare Associates
VERNON HILLS, Pa. A company that provides printing services for the healthcare industry and the country’s largest alternate-site GPO have signed a three-year agreement to provide barcode and card printers.
Zebra Technologies will provide Managed Healthcare Associates with its printers, as well as supplies and service agreements, at almost 500 of MHA’s member facilities for identification, tracking and access-control applications.
“Increasing patient safety is among the highest priorities in healthcare today,” MHA contract coordinator Kelly Decker said. “Having effective information technology in place is a key step in building a culture of safety that enables providers to improve outcomes and quality of care throughout their organizations.”
According to the Institute of Medicine, at least 1.5 million preventable adverse drug events happen every year in the United States, thought bar coding has been shown to reduce dangerous and expensive medical errors.
Drug adherence study shows that patients suffering despression often go off medication
NEW YORK A company that provides patient adherence and education programs released a study recently that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
The study, by Burlington, Mass.-based Adheris, found that patients new to antidepressant treatment and those who had restarted therapy after a lapse of six months or more were twice as likely to discontinue therapy in the first 30 days of treatment versus patients previously dispensed an antidepressant.
It also found that the greatest differences in the duration of antidepressant use were not among patients using different drugs, but among patients taking the same drug with different levels of prior experience with antidepressants.
The study appears in the September issue of the journal Clinical Therapeutics. It included more than 211,000 patients taking SSRI/SNRIs from 1,157 retail pharmacies across the country.